Detection of circulating immune complexes of human IgA and beta 2 glycoprotein I in patients with antiphospholipid syndrome symptomatology
- 1 July 2015
- journal article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 422, 51-58
Abstract
No abstract availableKeywords
Funding Information
- Fondo de Investigaciones Sanitarias (PI11/0444, PI14-00360)
This publication has 33 references indexed in Scilit:
- Alternative downstream processes for production of antibodies and antibody fragmentsBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2014
- A new trick for an ancient drug: quinine dissociates antiphospholipid immune complexesLupus, 2014
- The significance of autoantibodies against β2-glycoprotein IBlood, 2012
- Thromboprophylaxis in carriers of antiphospholipid antibodies (APL) without previous thrombosis: “Pros” and “Cons”Autoimmunity Reviews, 2012
- Primary prevention in antiphospholipid antibody carriersLupus, 2012
- Circulating β2 glycoprotein I-IgG anti-β2 glycoprotein I immunocomplexes in patients with definite Antiphospholipid SyndromeLupus, 2012
- Complement activation by (auto-) antibodiesMolecular Immunology, 2011
- β2‐Glycoprotein I: evolution, structure and functionJournal of Thrombosis and Haemostasis, 2011
- Primary Thrombosis Prophylaxis in Antiphospholipid Antibody–Positive Patients: Where Do We Stand?Current Rheumatology Reports, 2010
- Liver is not the unique site of synthesis of Β2-glycoprotein I (apolipoprotein H): evidence for an intestinal localizationInternational Journal of Clinical and Laboratory Research, 1997